NetworkNewsBreaks

WednesdayFeb 01, 2017 1:26 pm

NetworkNewsBreaks – Vericel (NASDAQ: VCEL) Shares Tick Higher; First U.S. Patient Receives MACI Implant to Treat Cartilage Defects of the Knee

Vericel (NASDAQ: VCEL) is up 4% mid-day after the company said the first patient in the United States has received the MACI® implant. MACI® is an autologous cellular scaffold product that is indicated for the repair of symptomatic single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. The MACI implant consists of human-derived cells (obtained from the patient's cartilage) seeded onto a resorbable type I/III collagen membrane. "We believe that the simplified MACI surgical technique, together with the MACI phase 3 clinical data demonstrating statistically significantly greater improvement in pain and function scores…

Continue Reading

WednesdayFeb 01, 2017 1:24 pm

NetworkNewsBreaks – Helios and Matheson Analytics (NASDAQ: HMNY) Completes Beta Testing to Add Artificial Intelligence to RedZone Map App, Shares Higher

Helios and Matheson Analytics (NASDAQ: HMNY), along with its Zone Technologies subsidiary, today announced the completion of beta testing of Zone's proprietary artificial intelligence (AI) technology. The AI integration is led by Dr. E.G. Rajan, chair and founding member of HMNY and Zone's Science & Technology Development Board, who has spent over 30 years researching AI and machine learning. Zone intends to include this AI technology in its RedZone Map app, providing features designed to analyze recent crime patterns and predict criminal activity. "The incorporation of artificial intelligence into RedZone Map will transform the app's data set into the ultimate…

Continue Reading

WednesdayFeb 01, 2017 12:32 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on February 1, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: NNSV 177.78% – News: Signs bio research agreement with Phage Consultants Co. SNBP 94.44% – News: Receives grant from NIH to study SBP-101 for the treatment of pancreatitis BRKK 26.09% – News: RefCAM used to broadcast portions of the NHL All-Star game PTCO 17.86% – News: Acquires mineral rights in Oklahoma VPRB 15.85% – News: Enters into exclusive distribution and sales agreement with Alpha-Cat MCIG 11.56% – News: Announces $200,000 investment from CEO and…

Continue Reading

WednesdayFeb 01, 2017 11:19 am

NetworkNewsBreaks – National Waste Management Holdings, Inc. (NWMH) Acquisition Expands Presence in New York

Solid waste management company National Waste Management Holdings, Inc. (OTC: NWMH) this morning announced some of the immediate growth opportunities stemming from its December acquisition of Northeast Data Destruction and Recycling, LLC. Notably, the acquisition immediately strengthened National Waste’s market reach in upstate New York, which now extends south to the Kingston, New York, headquarters of Northeast Data Destruction and Recycling. In line with its vertically integrated business model, the company plans to implement its existing offerings, including roll-off services, at its new Kingston operation in an effort to promote sustainable market growth. Looking forward, National Waste intends to continue…

Continue Reading

WednesdayFeb 01, 2017 11:16 am

NetworkNewsBreaks – ChineseInvestors.com (CIIX) Launches ChineseCBDoil.com Website; Featured in Interview Outlining Entry into Cannabis Industry

ChineseInvestors.com (OTCQB: CIIX) has launched a new website for its ChineseCBDoil.com subsidiary, through which CIIX is expanding into the medical marijuana industry. The site is an online retailer of hemp oil and related products, which are legal to sell and distribute within China as well as in the United States. “Our expertise in online communications with our background in media, technology, and journalism, via our http://www.Chinesefn.com website will further enhance our success,” CEO Warren Wang stated in the news release. “Our core business, the online distribution of news to the Chinese speaking population about financial markets and stocks has been…

Continue Reading

TuesdayJan 31, 2017 2:29 pm

NetworkNewsBreaks – Ocera Therapeutics (NASDAQ: OCRX) Steady with ‘Buy’ Rating, but Lower PT Following OCR-002 Top Line Results

Maintaining a ‘Buy’ rating on Ocera Therapeutics (NASDAQ: OCRX), Aegis Capital has lowered its price target on the company’s stock to $3 from $8. Ocera yesterday reported top-line results from its exploratory STOP-HE phase 2b study of OCR-002 in hospitalized patients with hepatic encephalopathy (HE). OCR-002 missed its primary endpoint, though results show dose-dependent clinical improvement. “The patients at the higher doses (15 and 20 grams) had faster clinical improvement and greater complete response rates compared to the patients on the lowest dose (10 grams) and those on placebo. These findings will be integral in determining dose levels for future…

Continue Reading

TuesdayJan 31, 2017 2:00 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 31, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DRYS 100.61% – News: Successfully completes $200M common stock offering SCDA 21.43% – News: Becomes one of CIOReview’s "20 Most Promising IoT Solution Providers 2017" GRSO 20.00% – News: Acquires West-Coast Organic FGCO 20.00% – News: Changes company name and symbol TLRS 16.63% – News: Posts positive preliminary results from on-going Talapoosa gold project NMUS 5.86% – News: Signs research agreement with the University of Mississippi to further explore NB2111 UNXL 3.15% – News:…

Continue Reading

TuesdayJan 31, 2017 11:45 am

NetworkNewsBreaks – eXp World Holdings, Inc.’s (EXPI) Unique Operations Support Environmental Sustainability

eXp World Holdings’ cloud-based real estate brokerage has many benefits for the company itself, but the perks of its structure help the environment as well.  “Companies such as eXp World Holdings, Inc. (OTCQB: EXPI) are completely changing the way the real estate industry itself functions. Gone are the days during which agents and brokers were expected to work in a brick and mortar office. EXPI has not only cut unnecessary expenses and built an agent-owned, cloud-based real estate brokerage that operates without the need for offices, utility bills, insurance, furnishings and redundant staffing costs, the company has correspondingly cut its…

Continue Reading

TuesdayJan 31, 2017 11:43 am

NetworkNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Positioned for Growth in $68.71B Market

Moxian, an offline-online (O2O) integrated platform operator, is set for growth in the booming O2O market. “Moxian, Inc. (NASDAQ: MOXC) is positioning itself as a leader in China’s O2O services market as the sector enjoys a 20% surge in year-over-year growth. iResearch Consulting Group, in its ‘2015 China Online-to-Offline (O2O) Services Model Research' … stated that the Chinese O2O market was on course to grow from $53.78 billion in 2015, to $68.71 billion in 2016. The report also forecast growth of 20% year-over-year through 2018 to more than $90 billion (http://nnw.fm/Jyj1C).” To view the full article, visit: http://nnw.fm/8XRdU About Moxian,…

Continue Reading

TuesdayJan 31, 2017 11:41 am

NetworkNewsBreaks – Sorrento Therapeutics, Inc. (NASDAQ: SRNE) Enriching Lives through Scientific Innovation

California-based biopharmaceutical company Sorrento Therapeutics (NASDAQ: SRNE) has a portfolio of OnTarget immunotherapies comprised of intracellular antibodies, immune checkpoint inhibitors, bispecific antibodies, and antibody-drug conjugates, as well as chimeric antigen receptor (CAR)-based cellular therapies. Through its TNK Therapeutics subsidiary, the company is also advancing adoptive cellular therapies utilizing the T cell as well as the Natural Killer cell. Sorrento has partnered with the City of Hope to form a joint venture, LA Cell, which is developing cell-internalizing mAbs against undruggable intracellular targets. Sorrento’s lead programs are four late-stage biosimilar and biobetter antibodies targeting an established market of more than $13…

Continue Reading